Vimal Mehta Bio Xcel Therapeutics, Inc. (BTAI) insider trading activity
Vimal Mehta is CEO and President of BioXcel Therapeutics, Inc.. Currently has a direct ownership of 20,111 shares of BTAI, which is worth approximately $136,754. The most recent transaction as insider was on May 14, 2023, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
20.1K
390.03%
3M change
57.7%
12M change
Total Value Held
$136,754
Vimal Mehta Transaction History
VM
Vimal Mehta
CEO and President
New Haven, CT